EU HTA and Joint Clinical Assessment
EU HTA establishes a common European framework for the clinical assessment of medicines and other health technologies. For medicines, the Joint Clinical Assessment (JCA) is a central component of this framework.
Delta Dossier brings together information, guides, current procedures and expert analyses on EU HTA and JCA.
JCA process
How does a Joint Clinical Assessment work? The guide explains scoping, the assessment scope, PICO, dossier submission and the European assessment process.
JCA dossier
What are the requirements for a JCA dossier? The guide explains the dossier structure, PICO-specific evidence and key requirements for submission.
Joint Scientific Consultation
How does a Joint Scientific Consultation work? The guide explains eligibility, the Briefing Package, PICO, the Outcome Document and the link to the subsequent JCA.
JCA Watch
Which Joint Clinical Assessments are currently underway? JCA Watch tracks initiated, ongoing and completed assessments and shows which medicines already have published JCA reports.
EU HTA Insights
What are the first JCA procedures showing in practice? The insights analyse published JCA reports, methodological questions, discontinued assessments and the links between European assessment and national HTA procedures.